√
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For
the quarterly period ended June 30, 2008
OR
|
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For
the transition period from
_____________
|
Delaware
|
20-3340900
|
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
(IRS
Employer Identification No.)
|
Large
accelerated filer
|
Accelerated
filer
|
Non-accelerated
filer √
|
Smaller
reporting company
|
(Unaudited)
June 30, 2008
|
December 31,
2007
|
|||||||
Assets
|
||||||||
Cash and cash
equivalents
|
$ | 1,584 | $ | 54,655 | ||||
Accounts
receivable, net of allowances for doubtful accounts of $42 at
June 30, 2008 and December 31, 2007
|
22,888 | 17,514 | ||||||
Inventory
|
26,302 | 24,192 | ||||||
Income taxes
receivable
|
304 | - | ||||||
Prepaid expenses
|
667 | 1,200 | ||||||
Marketable debt and auction rate
securities
|
69,333 | 15,086 | ||||||
Other current
assets
|
1,060 | 541 | ||||||
Total current
assets
|
122,138 | 113,188 | ||||||
Property, plant and equipment,
net
|
100,973 | 95,036 | ||||||
Restricted cash and cash
equivalents
|
3,341 | 3,263 | ||||||
Intangible assets
|
378 | 435 | ||||||
Other assets
|
3,246 | 4,191 | ||||||
Total noncurrent
assets
|
107,938 | 102,925 | ||||||
Total
Assets
|
$ | 230,076 | $ | 216,113 | ||||
Liabilities
and Stockholders’ Equity
|
||||||||
Accounts payable
|
$ | 12,408 | $ | 12,622 | ||||
Accounts payable – related
parties
|
230 | 121 | ||||||
Income taxes
payable
|
- | 1,231 | ||||||
Current deferred income tax
liability
|
4,378 | 4,597 | ||||||
Short term contingent
consideration
|
657 | 197 | ||||||
Accrued expenses and other
current liabilities
|
3,632 | 3,370 | ||||||
Total current
liabilities
|
21,305 | 22,138 | ||||||
Long term contingent
consideration
|
1,413 | 1,989 | ||||||
Deferred revenue
|
6,749 | 1,571 | ||||||
Other noncurrent
liabilities
|
1,204 | 1,126 | ||||||
Noncurrent deferred income tax
liability
|
20,354 | 19,667 | ||||||
Total noncurrent
liabilities
|
29,720 | 24,353 | ||||||
Total
Liabilities
|
51,025 | 46,491 | ||||||
Commitments
and contingencies
|
||||||||
Preferred
stock, $0.0001 par value, 5,000,000 shares authorized, none issued and
outstanding
|
- | - | ||||||
Common
stock, $0.0001 par value, 75,000,000 shares authorized, 26,700,000 issued
and outstanding at June 30, 2008 and 26,700,000 issued and
outstanding at December 31, 2007
|
3 | 3 | ||||||
Accumulated other comprehensive
income
|
87 | 58 | ||||||
Additional paid in
capital
|
158,763 | 158,436 | ||||||
Retained earnings
|
20,198 | 11,125 | ||||||
Total stockholders’
equity
|
179,051 | 169,622 | ||||||
Total
Liabilities and Stockholders’ Equity
|
$ | 230,076 | $ | 216,113 |
Three
Months Ended June 30,
|
||||||
2008
|
2007 | |||||
Revenues
|
$ | 49,896 | $ | 41,580 | ||
Revenues
– related parties
|
- | 40 | ||||
Cost
of goods sold
|
43,720 | 35,491 | ||||
Cost
of goods sold – related parties
|
846 | 83 | ||||
Distribution
|
879 | 464 | ||||
Gross
profit
|
4,451 | 5,582 | ||||
Selling,
general and administrative expenses
|
||||||
Compensation
expense
|
890 | 444 | ||||
Formation expense
|
- | 74 | ||||
Other expense
|
249 | 251 | ||||
Related party
expense
|
66 | 53 | ||||
Research
and development expenses
|
1,008 | 678 | ||||
2,213 | 1,500 | |||||
Income
from operations
|
2,238 | 4,082 | ||||
Interest
income
|
846 | 877 | ||||
Interest
expense
|
(5 |
)
|
(8 | ) | ||
Gain
on foreign currency
|
511 | 5 | ||||
Gain
on sale of marketable debt securities
|
83 | - | ||||
Other
expense
|
- | (68 | ) | |||
1,435 | 806 | |||||
Income
before income taxes
|
3,673 | 4,888 | ||||
Provision
for income taxes
|
760 | 1,981 | ||||
Net
income
|
$ | 2,913 | $ | 2,907 | ||
Earnings
per common share
|
||||||
Basic
|
$ | 0.11 | $ | 0.11 | ||
Diluted
|
$ | 0.11 | $ | 0.09 | ||
Weighted
average shares outstanding
|
||||||
Basic
|
26,700,000 | 26,700,000 | ||||
Diluted
|
26,735,387 | 32,045,246 | ||||
Comprehensive
Income
|
||||||
Net
income
|
$ | 2,913 | $ | 2,907 | ||
Other
comprehensive loss, net of tax benefit of $14 in 2008
|
(24 |
)
|
- | |||
Comprehensive
income
|
$ | 2,889 | $ | 2,907 |
Six Months Ended June 30, | ||||||||
|
2008 | 2007 | ||||||
Revenues
|
$ | 93,116 | $ | 79,087 | ||||
Revenues
– related parties
|
- | 40 | ||||||
Cost
of goods sold
|
74,933 | 75,150 | ||||||
Cost
of goods sold – related parties
|
1,582 | 83 | ||||||
Distribution
|
1,568 | 760 | ||||||
Gross
profit
|
15,033 | 3,134 | ||||||
Selling,
general and administrative expenses
|
||||||||
Compensation
expense
|
1,328 | 761 | ||||||
Formation expense
|
- | 74 | ||||||
Other expense
|
553 | 705 | ||||||
Related party
expense
|
104 | 83 | ||||||
Research
and development expenses
|
1,964 | 1,669 | ||||||
3,949 | 3,292 | |||||||
Income
(loss) from operations
|
11,084 | (158 | ) | |||||
Interest
income
|
1,616 | 1,819 | ||||||
Interest
expense
|
(11 | ) | (13 | ) | ||||
Gain
on foreign currency
|
381 | 5 | ||||||
Gain
on sale of marketable debt securities
|
83 | - | ||||||
Other
income (expense)
|
6 | (68 | ) | |||||
2,075 | 1,743 | |||||||
Income
before income taxes
|
13,159 | 1,585 | ||||||
Provision
for income taxes
|
4,086 | 718 | ||||||
Net
income
|
$ | 9,073 | $ | 867 | ||||
Earnings
per common share
|
||||||||
Basic
|
$ | 0.34 | $ | 0.03 | ||||
Diluted
|
$ | 0.34 | $ | 0.03 | ||||
Weighted
average shares outstanding
|
||||||||
Basic
|
26,700,000 | 26,700,000 | ||||||
Diluted
|
26,717,693 | 32,037,968 | ||||||
Comprehensive
Income
|
||||||||
Net
income
|
$ | 9,073 | $ | 867 | ||||
Other
comprehensive income, net of tax of $18 in 2008
|
29 | - | ||||||
Comprehensive
income
|
$ | 9,102 | $ | 867 |
Six Months Ended June 30,
|
||||||||
2008 | 2007 | |||||||
Cash flows provide by operating activities | ||||||||
Net income
|
$ | 9,073 | $ | 867 | ||||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
||||||||
Depreciation
|
2,743 | 2,127 | ||||||
Provision
for deferred income taxes
|
461 | 349 | ||||||
Change
in fair value of derivative instruments
|
274 | 946 | ||||||
Accretion
of the discount of marketable debt securities
|
(90 | ) | - | |||||
Losses
on disposals of fixed assets
|
10 | 112 | ||||||
Stock
based compensation
|
327 | - | ||||||
Noncash
interest expense
|
11 | 11 | ||||||
Changes
in operating assets and liabilities:
|
||||||||
Accounts
receivable
|
(5,374 | ) | 2,565 | |||||
Inventory
|
(2,866 | ) | 1,508 | |||||
Income taxes
receivable
|
(304 | ) | (853 | ) | ||||
Prepaid expenses
|
533 | 661 | ||||||
Accrued interest on marketable
debt securities
|
(296 | ) | - | |||||
Other assets
|
945 | (305 | ) | |||||
Accounts payable
|
(214 | ) | 1,623 | |||||
Accounts
payable – related parties
|
109 | 68 | ||||||
Income taxes
payable
|
(1,231 | ) | (1,916 | ) | ||||
Accrued expenses and other
current liabilities
|
262 | 423 | ||||||
Accrued
expenses and other current liabilities – related parties
|
- | (40 | ) | |||||
Deferred
revenue
|
5,178 | - | ||||||
Other
noncurrent liabilities
|
56 | 190 | ||||||
Net
cash provided by operating activities
|
9,607 | 8,336 | ||||||
Cash
flows used in investing activities
|
||||||||
Restricted cash
|
(78 | ) | (74 | ) | ||||
Collateralization of derivative
instruments
|
(793 | ) | 1,444 | |||||
Purchase of marketable
securities
|
(24,992 | ) | - | |||||
Proceeds from the sale of
marketable securities
|
30,080 | - | ||||||
Purchase of auction rate
securities, net
|
(58,900 | ) | - | |||||
Proceeds from the sale of fixed
assets
|
8 | - | ||||||
Contingent purchase price
payment
|
(117 | ) | (59 | ) | ||||
Capital
expenditures
|
(7,886 | ) | (9,806 | ) | ||||
Net
cash used in investing activities
|
(62,678 | ) | (8,495 | ) | ||||
Cash
flows used in financing activities
|
||||||||
Financing fee
|
- | (50 | ) | |||||
Net cash used in financing
activities
|
- | (50 | ) | |||||
Net
change in cash and cash equivalents
|
(53,071 | ) | (209 | ) | ||||
Cash
and cash equivalents at beginning of period
|
54,655 | 63,129 | ||||||
Cash
and cash equivalents at end of period
|
$ | 1,584 | $ | 62,920 | ||||
Cash
paid for interest
|
$ | - | $ | 3 | ||||
Cash
paid for taxes
|
$ | 5,103 | $ | 2,992 |
June 30,
2008
|
December 31,
2007
|
|||||||
At
first-in, first-out or average cost (approximates current
cost)
|
||||||||
Finished goods
|
$ | 11,059 | $ | 8,993 | ||||
Work in process
|
1,546 | 1,091 | ||||||
Raw materials and
supplies
|
16,701 | 15,670 | ||||||
29,306 | 25,754 | |||||||
LIFO reserve
|
(3,004 | ) | (1,562 | ) | ||||
Total inventories
|
$ | 26,302 | $ | 24,192 |
Asset/(Liability)
|
||||||||||||||||
June
30, 2008
|
December 31,
2007
|
|||||||||||||||
Quantity
(Contracts) Long/ (Short)
|
Fair
Market Value
|
Quantity
(Contracts) Long/ (Short)
|
Fair
Market Value
|
|||||||||||||
Regulated
options, included in prepaid expenses and other current
assets
|
(125 | ) | $ | (521 | ) | (100 | ) | $ | (247 | ) |
June 30,
2008
|
December 31,
2007
|
|||||||
Accrued
employee liabilities
|
$ | 2,170 | $ | 1,722 | ||||
Accrued
property, use and franchise taxes
|
1,396 | 1,110 | ||||||
Accrued
professional fees
|
30 | 30 | ||||||
Other
|
36 | 508 | ||||||
Total
|
$ | 3,632 | $ | 3,370 |
Leverage
Ratio
|
Base
Rate
Margin
|
LIBOR
Margin
|
||
>
3
|
-0.55%
|
1.70%
|
||
≥ 2
< 3
|
-0.70%
|
1.55%
|
||
≥ 1
< 2
|
-0.85%
|
1.40%
|
||
<
1
|
-1.00%
|
1.25%
|
|
·
|
Encourage
ownership in FutureFuel by key personnel whose long-term employment with
or engagement by FutureFuel or its subsidiaries is considered essential to
its continued progress and, thereby, encourage recipients to act in
FutureFuel’s shareholders’ interests and share in its
success;
|
|
·
|
Encourage
such persons to remain in FutureFuel’s employ or in the employ of its
subsidiaries; and
|
|
·
|
Provide
incentives to persons who are not FutureFuel employees to promote
FutureFuel’s success.
|
Assumptions
|
Director
Options
|
Management
Options
|
||||||
Expected
volatility rate
|
46.78 | % | 48.74 | % | ||||
Expected
dividend yield
|
0.00 | % | 0.00 | % | ||||
Risk-free
interest rate
|
2.03 | % | 2.26 | % | ||||
Expected
forfeiture rate
|
0.00 | % | 0.00 | % | ||||
Expected
term in years
|
2.50 | 3.50 |
Options
|
Weighted-Average
Exercise Price
|
|||||||
Outstanding
at January 1, 2008
|
- | - | ||||||
Granted
|
305,000 | $ | 4.00 | |||||
Exercised
|
- | - | ||||||
Cancelled,
forfeited or expired
|
- | - | ||||||
Outstanding
at June 30, 2008
|
305,000 | $ | 4.00 | |||||
Weighted
average remaining contractual life
|
4.77
years
|
|||||||
Options
exercisable at June 30, 2008
|
250,000 | $ | 4.00 | |||||
Weighted
average fair value of the options granted
|
n/a | $ | 1.31 | |||||
Available
for grant at June 30, 2008
|
2,365,000 | n/a |
Options
Outstanding
|
Options
Exercisable
|
|||||||||
Exercise
Price
|
Number
Outstanding
at
June 30,
2008
|
Weighted-Average
Remaining Contractual Life
|
Weighted-Average
Exercise Price
|
Number
Exercisable
at
June 30,
2008
|
Weighted-
Average Exercise Price
|
|||||
$ 4.00
|
305,000
|
4.77
years
|
$ 4.00
|
250,000
|
$ 4.00
|
For
the three months ended June 30,
|
For
the six months ended
June 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Provision
for income taxes
|
$ | 760 | $ | 1,981 | $ | 4,086 | $ | 718 | ||||||||
Effective
tax rate
|
20.7 | % | 40.5 | % | 31.1 | % | 45.3 | % |
For
the three months ended June 30,
|
For
the six months ended June 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Net
income available to common stockholders
|
$ | 2,913 | $ | 2,907 | $ | 9,073 | $ | 867 | ||||||||
Weighted
average number of common shares outstanding
|
26,700,000 | 26,700,000 | 26,700,000 | 26,700,000 | ||||||||||||
Effect
of warrants
|
- | 5,345,246 | - | 5,337,968 | ||||||||||||
Effect
of stock options
|
35,387 | - | 17,673 | - | ||||||||||||
Weighted
average diluted number of common shares outstanding
|
26,735,387 | 32,045,246 | 26,717,673 | 32,037,968 | ||||||||||||
Basic
earnings per share
|
$ | 0.11 | $ | 0.11 | $ | 0.34 | $ | 0.03 | ||||||||
Diluted
earnings per share
|
$ | 0.11 | $ | 0.09 | $ | 0.34 | $ | 0.03 |
Three
Months Ended
|
United
States
|
All
Foreign Countries
|
Total
|
|||||||||
June 30,
2008
|
$ | 42,260 | $ | 7,636 | $ | 49,896 | ||||||
June 30,
2007
|
$ | 35,882 | $ | 5,739 | $ | 41,620 |
Six
Months Ended
|
United
States
|
All
Foreign Countries
|
Total
|
|||||||||
June 30,
2008
|
$ | 78,665 | $ | 14,451 | $ | 93,116 | ||||||
June 30,
2007
|
$ | 68,182 | $ | 10,945 | $ | 79,127 |
For
the three months ended June 30,
|
For
the six months ended June 30,
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Revenues
|
||||||||||||||||
Chemicals
|
$ | 33,980 | $ | 34,414 | $ | 72,696 | $ | 70,069 | ||||||||
Biofuels
|
15,916 | 7,206 | 20,420 | 9,058 | ||||||||||||
Revenues
|
$ | 49,896 | $ | 41,620 | $ | 93,116 | $ | 79,127 | ||||||||
Segment
gross margins
|
||||||||||||||||
Chemicals
|
$ | 6,997 | $ | 5,274 | $ | 15,437 | $ | 10,721 | ||||||||
Biofuels
|
(2,546 | ) | 308 | (404 | ) | (7,587 | ) | |||||||||
Segment
gross margins
|
4,451 | 5,582 | 15,033 | 3,134 | ||||||||||||
Corporate
expenses
|
(2,213 | ) | (1,500 | ) | (3,949 | ) | (3,292 | ) | ||||||||
Income
(loss) before interest and taxes
|
2,238 | 4,082 | 11,084 | (158 | ) | |||||||||||
Interest
and other income
|
1,440 | 882 | 2,086 | 1,824 | ||||||||||||
Interest
and other expense
|
(5 | ) | (76 | ) | (11 | ) | (81 | ) | ||||||||
Provision
for income taxes
|
(760 | ) | (1,981 | ) | (4,086 | ) | (718 | ) | ||||||||
Net
income (loss)
|
$ | 2,913 | $ | 2,907 | $ | 9,073 | $ | 867 |
Asset/(Liability)
|
||||||||||||||||
Fair
Value at June 30,
|
Fair
Value Measurements Using
Inputs
Considered as
|
|||||||||||||||
Description
|
2008
|
Level
1
|
Level
2
|
Level
3
|
||||||||||||
Available
for sale:
|
||||||||||||||||
Treasury
bonds of a certain foreign government
|
$ | 10,349 | $ | 10,349 | $ | - | $ | - | ||||||||
Auction
rate securities
|
$ | 58,984 | $ | - | $ | 58,984 | $ | - | ||||||||
Derivative
instruments
|
$ | (521 | ) | $ | (521 | ) | $ | - | $ | - |
June 30,
2008
|
June 30,
2007
|
|||||||
Net
cash provided by operating activities
|
$ | 9,607 | $ | 8,336 | ||||
Net
cash used in investing activities
|
(62,678 | ) | $ | (8,495 | ) | |||
Net
cash used in financing activities
|
$ | - | $ | (50 | ) |
Item
|
Volume(a)
Requirements
|
Units
|
Hypothetical
Adverse
Change
in
Price
|
Decrease
in Gross Profit
|
Percentage
Decrease
in
Gross
Profit
|
|||||
Animal
fat
|
39,624,289
|
LB
|
10.0%
|
$ 1,709
|
11.2%
|
|||||
Electricity
|
46,672
|
MWH
|
10.0%
|
$ 265
|
1.7%
|
|||||
Caustic
soda
|
13,359,382
|
LB
|
10.0%
|
$ 188
|
1.2%
|
|||||
Coal
|
26,993
|
Ton
|
10.0%
|
$ 185
|
1.2%
|
|||||
Natural
gas
|
157,362
|
KSCF
|
10.0%
|
$ 174
|
1.2%
|
(a)
|
Volume
requirements and average price information are based upon volumes used and
prices obtained for the six months ended June 30,
2008. Volume requirements may differ materially from these
quantities in future years as the business of FutureFuel Chemical Company
evolves.
|
|
·
|
Edwin
A. Levy and Donald C. Bedell were reelected as Class A directors for
terms expiring at the 2010 annual meeting of shareholders. In
each case, the result was 17,487,429 votes “for” reelection and 250,000
votes against reelection.
|
|
·
|
Lee
E. Mikles and Thomas R. Evans were reelected as Class B directors for
terms expiring at the 2011 annual meeting of shareholders. In
each case, the result was 17,487,429 votes “for” reelection and 250,000
votes against reelection.
|
|
·
|
The
withdrawal of the admission of FutureFuel Corp.’s common stock to the AIM
market of the London Stock Exchange plc was approved, to be effective
July 14, 2008. The result was 17,487,429 votes for and
250,000 votes against.
|
|
·
|
The
ratification of the appointment of RubinBrown LLP as FutureFuel Corp.’s
independent auditors for 2007 and 2008 was approved. The result
was 17,487,429 votes for and 250,000 votes
against.
|
Exhibit
No.
|
Description
|
10.7
|
Purchase
Agreement made and entered into as of April 1, 2008 between The
Procter & Gamble Manufacturing Company, The Procter & Gamble
Distributing LLC and Procter & Gamble International Operations SA, as
buyer, and FutureFuel Chemical Company, as seller
|
31(a)
|
Rule
13a-15(e)/15d-15(e) Certification of chief executive
officer
|
31(b)
|
Rule
13a-15(e)/15d-15(e) Certification of principal financial
officer
|
32
|
Section
1350 Certification of chief executive officer and principal financial
officer
|
·
|
conflicts
of interest of our officers and
directors;
|
·
|
potential
future affiliations of our officers and directors with competing
businesses;
|
·
|
the
control by our founding shareholders of a substantial interest in
us;
|
·
|
the
highly competitive nature of the chemical and alternative fuel
industries;
|
·
|
fluctuations
in energy prices may cause a reduction in the demand or profitability of
the products or services we may ultimately produce or offer or which form
a portion of our business;
|
·
|
changes
in technology may render our products or services
obsolete;
|
·
|
failure
to comply with governmental regulations could result in the imposition of
penalties, fines or restrictions on operations and remedial
liabilities;
|
·
|
the
operations of FutureFuel Chemical Company’s biofuels business may be
harmed if the applicable government were to change current laws and/or
regulations;
|
·
|
our
board may have incorrectly evaluated FutureFuel Chemical Company’s
potential liabilities;
|
·
|
our
board may have FutureFuel Chemical Company engage in hedging transactions
in an attempt to mitigate exposure to price fluctuations in petroleum
product transactions and other portfolio positions which may not
ultimately be successful; and
|
·
|
we
may not continue to have access to capital markets and commercial bank
financing on favorable terms and FutureFuel Chemical Company may lose its
ability to buy on open credit
terms.
|